The investment follows earlier support from the Paulson Family Foundation for Hebrew University’s engineering and computer-science infrastructure. That support includes the Paulson Bar-El Building for Computer Science & Engineering and the John Paulson Building for Electrical Engineering on the Edmond J. Safra Campus. The new award extends that involvement from individual facilities and disciplines to a university-wide program centered on areas described as nationally important. Hebrew University said the gift would help it recruit faculty, support students, equip laboratories and increase the capacity of research infrastructure. Technically, this means the funding can connect several parts of the scientific process: education, basic investigation, development of equipment and methods, and the translation of findings into clinical, industrial or public applications.

A central element will be the development of Hebrew University’s new Faculty of Engineering. The planned faculty is intended to bring engineering, computer science, medicine and the life sciences into a more connected structure for addressing complex technological and social problems. That combination is especially relevant in fields where advances depend on hardware, software, biological knowledge and clinical observation working together. Medical devices, for example, require electrical and mechanical engineering as well as testing with physicians and patients; computational methods can help researchers analyze large biological datasets; and biomedical engineering can translate cellular mechanisms into diagnostic tools or therapeutic systems. By treating these areas as parts of a shared enterprise rather than isolated departments, the university aims to create research teams capable of moving from questions in basic science to practical systems.

Paulson’s gift will also strengthen the university’s medical and biomedical ecosystem, encompassing research, infrastructure and innovation in medical education. Hebrew University said the money would help advance an emerging model for medical education, broaden its reach and deepen the research and technological foundations beneath the curriculum. A modern medical curriculum depends on more than classroom instruction. Students and researchers need laboratories, imaging facilities, data resources, clinical partnerships and access to sophisticated equipment. The same infrastructure can support investigations into disease mechanisms, new diagnostic approaches and better methods of treatment. The announcement did not specify individual projects, although the scale of the gift suggests that it is intended to provide durable capacity rather than finance a narrow, short-term program.

Trauma and post-trauma recovery form another major component of the award. These are complex problems because serious injury can produce interconnected physical and psychological effects that may continue long after the initial event. A research response can therefore require expertise in emergency care, surgery, rehabilitation, neuroscience, psychology and public health. The university said the gift would support research in this area, although the source announcement did not release a detailed agenda, project list or set of clinical targets. Its broader purpose is to give investigators and practitioners the resources required to examine recovery across biological, functional and social dimensions, an approach that can connect laboratory findings with the longer-term needs of patients and families.

The donation will also help establish an impact and community think tank designed to bring the university’s academic expertise into closer dialogue with urgent public needs in Israel and internationally. Such an organization would function as an interface between researchers, public institutions, community organizations, policymakers and other users of specialized knowledge. The announcement presented the think tank as a new framework for public impact rather than as a single laboratory. Its potential value lies in helping turn evidence into decisions: identifying where research can answer practical questions, assembling evidence across disciplines, and communicating uncertainties as well as findings. Because the source did not provide a formal charter, membership model or funding schedule, the think tank’s eventual structure and priorities remain to be defined.

The university describes the gift as support for a broad effort to strengthen Israel’s innovation economy, educate future leaders and produce benefits beyond the campus. That framing reflects the character of research-intensive institutions, where discovery often depends on long horizons and on people moving between laboratories, clinical settings and classrooms. Paulson said he believed investment in Hebrew University could offer substantial value relative to the cost of comparable education and research infrastructure in the United States. He also characterized the donation as an expression of support and international solidarity with Israel. These statements establish the donor’s stated motivation, while the scientific impact of the gift will ultimately depend on how the funds are allocated and on the research projects, collaborations and training programs that emerge over time.

The award arrives as Hebrew University enters its second century and marks a moment of transition in its history. The university’s cornerstone was laid on Mount Scopus in 1918, seven years before it formally opened in 1925, and its founding vision involved figures including Albert Einstein and Sigmund Freud. The renamed campus thus connects a major contemporary investment with the institution’s origins. The university says its work has included more than 10,750 patents and major international distinctions, including ten Nobel Prizes, two Turing Awards and a Fields Medal. In 2026, it was ranked 89th globally in the Shanghai Ranking. Those institutional achievements provide context for the scale of the campaign, but the new gift is also forward-looking: its scientific significance will be measured by the people trained, laboratories strengthened, interdisciplinary programs created and problems solved in the years ahead.

For the research community, the most consequential feature of the donation may be its capacity to reduce fragmentation. Large multidisciplinary awards can support the infrastructure around individual discoveries as well as the discoveries themselves. In engineering and medicine, that can include shared facilities, advanced instruments, computing resources, data systems and specialized staff. It can also fund the less visible components of a research culture, such as fellowships, visiting scholars, pilot studies, training and collaboration across organizational boundaries. If the new faculty, medical initiatives, trauma programs and public-impact think tank are integrated effectively, the gift could create a connected pathway from education to investigation, from investigation to application, and from application to community benefit. The announcement does not yet provide outcome measures, and it makes no claim that particular medical advances or engineering breakthroughs have already resulted. Its immediate significance is instead the creation of substantial, long-term capacity at Hebrew University for conducting and applying high-impact science.

Subject of Research: A $250 million Hebrew University donation supporting engineering, medicine, trauma recovery and public-impact research.

Article Title: Historic $250 million gift from John Paulson to Hebrew University will advance engineering, medicine, and trauma recovery

Article References: Historic $250 million gift from John Paulson to Hebrew University will advance engineering, medicine, and trauma recovery. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: Hebrew University, John Paulson, philanthropy, engineering education, biomedical research, trauma recovery, medical education, public impact, Jerusalem, research infrastructure, Historic, million

The timing of the argument is not accidental. The COVID-19 pandemic offered a stress test of how science reaches the public, and the results were sobering. Rapidly evolving evidence forced frequent updates to public health guidance, but inconsistent messaging and inadequate explanation of scientific uncertainty bred confusion. Social media amplified both accurate information and misleading claims at unprecedented speed, and simplified or sensational narratives frequently outran nuanced, evidence-based explanations. The authors argue that the pandemic did not create these weaknesses but exposed them, revealing that the institutions and incentives supporting science communication have not evolved at the pace required by a decentralized, algorithmically mediated information environment.

The first stage of breakdown occurs before a finding ever leaves the laboratory’s orbit. Peer-reviewed journals remain the gold standard for communication within the biomedical community, prized for their rigorous scientific and editorial oversight. Yet the path to publication is fraught. Manuscript submission fees can be prohibitive, rejection rates are high, and peer review and editorial processes are lengthy. The imbalance between available peer reviewers and the volume of manuscripts awaiting review has worsened since the pandemic, and it has been compounded as submission numbers climb, driven in part by researchers using large language models to draft manuscripts. Publishing incentives also favor positive findings and novel discoveries over the confirmatory studies and negative data that build a complete evidence base.

Access is the other half of the problem. Full-length journal articles often sit behind expensive paywalls, and even when they are readable, dense field-specific terminology and technical precision prioritized over clear storytelling can render them impenetrable to biomedical professionals outside a given specialty. Many journals have introduced remedies, including open access options, required plain-language summaries, and graphical abstracts, but adoption is inconsistent and enforcement is weak. Plain-language summaries remain relatively uncommon or overly technical, and graphical abstracts can themselves create accessibility barriers for some audiences. The result is a system in which even the professionals most likely to translate research for others struggle to obtain and understand it.

The authors propose a layered set of fixes for this first stage. Journals can use their own data on readership, citation metrics, and digital engagement to evaluate which editorial policies actually work and to refine guidelines for data sharing and plain-language summaries. Research institutions can retain department- and school-level support from in-house statisticians, graphic designers, technical writers, and communications specialists, and extend equitable access to those staff regardless of a research team’s size or funding. Researchers themselves are urged to write for the professional backgrounds of their intended audiences, to describe the conditions under which findings apply while acknowledging limitations and uncertainty, to develop fluency in accessible visual communication, and to use preprint outlets when publication costs are prohibitive. Philanthropic funders, meanwhile, can incentivize these practices among grantees; the authors cite the Misophonia Research Fund, which engaged a communications firm to strengthen grantees’ skills and hosted a virtual forum to share findings with both the biomedical community and the public.

The second stage, interpretation and distribution, is where the telephone game gets truly dangerous. Once research is published, findings are picked up, translated, and repackaged for different audiences, and every act of reinterpretation is an opportunity to introduce inaccuracy. Science journalism sits at the center of this relay, and it is struggling badly. As the advertising-based model that historically supported news platforms collapses, legacy media organizations have lost reporting capacity, particularly in specialized areas like science. The United States is losing an average of more than two newspapers per week, and the spread of news deserts, communities with few or no local news sources, matters because local news is highly trusted and has significant reach, making it a key vehicle for disseminating accurate scientific information. The contraction also means fewer opportunities for specialized training: most journalists are generalists, and fewer than 3 percent bring an undergraduate science major to their reporting.

As journalism recedes, other actors fill the vacuum, often without preparation. Clinical and research scientists increasingly post on social media, write for public audiences, and engage with reporters, but they are not typically trained in public communication and risk misrepresenting nuance or uncertainty in ways that inadvertently undermine trust. Misinformation compounds the problem. Although blame often falls on social media, the authors note that inaccurate scientific information stems from many sources, including corporations, government offices, entertainment media, press offices, individual scientists, healthcare professionals, and research institutions. AI platforms and large language model chatbots now serve as additional distribution channels, with the potential to amplify both accurate and misleading content. Because misinformation thrives in the absence of easily accessible, credible information, the authors argue that everyone participating in the ecosystem bears responsibility for sharing reliable science.

Remedies for the distribution stage already exist and can be scaled. Training programs and fellowships support specialized science journalism, exemplified by the Knight Science Journalism Academic-Year fellows who spend a year at MIT exploring research and honing technical skills. Scientific societies can train scientists to work with journalists: SciLine, developed by the American Association for the Advancement of Science, offers journalists free training, resources for evidence-based reporting, and a matching service that pairs reporters with scientific experts, while scientists in its network receive media training. Universities can embed communication skills in scientific training, as Stony Brook University does through a science communication certification offered with the Alan Alda Center for Communicating Science during doctoral study. Philanthropy has a distinctive opening here, exemplified by Press Forward, a national network led by the MacArthur Foundation that aims to strengthen local news and close coverage gaps by lowering barriers for new funders. Because much philanthropic giving is place-based and rooted in personal interests, the authors argue that science journalism, sitting at the intersection of those domains, can appeal to many funders.

The third stage, public engagement, is where the paradox of modern science communication becomes starkest. Polling from the Pew Research Center reported in April 2026 found that 85 percent of Americans obtain science and health information at least sometimes from healthcare providers, 66 percent from people with similar health experiences, and 60 percent from major health websites such as WebMD or Mayo Clinic. Journalists and news organizations were cited by 46 percent, government health agencies by 45 percent, social media by 36 percent, and AI chatbots by 22 percent. Yet despite this abundance of channels, global and US public confidence in the ability to find reliable answers and make informed health decisions has significantly declined in the past year, according to the Edelman Trust Barometer. The authors attribute this paradox to the multiple layers of reinterpretation in the current pipeline: different platforms deliver conflicting or oversimplified narratives, leaving audiences uncertain about what to believe and more likely to gravitate toward the most prominent or emotionally compelling voices.

The encouraging news is that trust itself is not the missing ingredient. Roughly 70 percent of Americans report at least moderate trust in scientists to act in the public’s best interest, and about 75 percent prioritize sources that demonstrate relevant medical expertise, disclose conflicts of interest, and present information clearly. Preferences vary across populations: people with lower incomes or less formal education are more likely to prioritize likability and relatability, while those without health insurance often emphasize convenience, including access through social media and AI platforms. The central weakness, the authors conclude, is a misalignment between trust, accessibility, and communication pathways. Their recommendations include having academic medical centers incentivize faculty and clinicians to engage in outreach and pair them with professional science communicators, as the Mayo Clinic has done by counting digital and social media scholarship among criteria for academic advancement. Community-level partnerships matter too: the Barbershop Talk with Brothers program, a collaboration between the Arthur Ashe Institute for Urban Health and SUNY Downstate Medical Center, trains barbers who are trusted advisors in Brooklyn to communicate evidence-based health information. Structural incentives, such as tying grants or accreditation to demonstrated public communication, and philanthropic support for programs like the ARVO Science Communication Training Fellowship could make outreach a core component of scientific careers. The challenge, in the authors’ framing, is not a deficit of public trust in science but the failure to ensure that accurate, transparent, and understandable information is easy to find, easy to engage with, and easy to trust, and philanthropy’s risk-tolerant capital may be the force best positioned to rebuild those connections.

Subject of Research: Redesigning the biomedical science communication ecosystem from publication to public engagement

Article Title: Bridging communication gaps across the biomedical ecosystem

Article References: Burke, E. A., Schumm, S. N., Jobe, A., Whelply, K., & Das, I. (2026). Bridging communication gaps across the biomedical ecosystem. Frontiers in Systems Biology, 6, Article 1939110. https://doi.org/10.3389/fsysb.2026.1939110

Image Credits: AI Generated

DOI: 10.3389/fsysb.2026.1939110

Keywords: science communication, biomedical research, peer review, misinformation, science journalism, social media, large language models, public trust, philanthropy, health information, news deserts, community health

The chair itself is a relatively new institution, established in 2023 through a £2 million philanthropic gift from Professor Raymond F. Schinazi, a University of Bath alumnus whose career has become one of the most remarkable stories in modern antiviral research. Schinazi studied Chemistry at Bath, completing both his undergraduate degree and his doctorate there before building a distinguished career in academia and biotechnology in the United States. His pioneering work led to the development of antiviral medicines for HIV, hepatitis B and hepatitis C, and medicines developed through his research continue to benefit millions of patients worldwide. The chair bearing his name was created to attract scientists capable of following a similar trajectory, linking fundamental chemistry to therapies with global reach.

Schinazi himself welcomed the appointment, saying he was delighted that Bower would be the next holder of the chair. Throughout his career, he noted, he has seen how advances in chemistry can provide the foundation for breakthrough medicines that improve and save lives. In his view, Bower is an outstanding scientist who is exceptionally well placed to help advance Bath’s research strengths in medicinal chemistry and drug discovery. The endorsement carries particular weight coming from a donor whose own scientific legacy demonstrates exactly the kind of impact the endowment is designed to catalyse.

So what exactly does a synthetic and medicinal chemist of Bower’s standing do? At its core, synthetic organic chemistry is the science of building molecules, atom by atom and bond by bond, from simpler starting materials. When the target molecules are biologically active, the discipline becomes the engine room of drug discovery: nearly every small-molecule medicine on the pharmacy shelf, from antibiotics to antivirals to anticancer agents, exists because chemists worked out how to construct it efficiently, selectively and, increasingly, sustainably. The craft demands mastery of catalysis, the use of substances that accelerate and steer chemical reactions, and of molecular design, the rational shaping of a molecule’s three-dimensional architecture so that it interacts precisely with biological targets such as enzymes or receptors.

Bower’s research programme sits squarely at this intersection. His work combines synthetic organic chemistry, catalysis and molecular design to develop new sustainable processes for the synthesis of biologically active molecules. That emphasis on sustainability reflects a broader shift across the pharmaceutical and fine-chemical industries, where traditional synthesis routes can be lengthy, wasteful and reliant on hazardous reagents. Modern catalytic methods, by contrast, can shorten synthetic sequences, reduce solvent use and waste, and open access to molecular structures that would otherwise be impractical to make. For medicinal chemistry, the practical consequence is enormous: when a promising drug candidate can be assembled in fewer steps and higher yield, researchers can prepare more analogues more quickly, accelerating the optimisation cycles that turn a laboratory hit into a developable medicine.

Bower’s path to Bath traces a classic route through some of the strongest chemistry departments in the world. He obtained his MSci degree in Chemistry and his PhD from the University of Bristol, before pursuing postdoctoral positions at the University of Texas at Austin and the University of Oxford, two environments renowned for pushing the frontiers of synthetic methodology. He then returned to Bristol to establish his independent research group, building the reputation that led to his move to Liverpool ten years later, in 2020, where he was appointed Regius Professor of Chemistry. The Regius professorships are royal appointments of great historical distinction, and holding one marks a chemist out as being at the very top of the discipline in the United Kingdom.

His arrival in Bath is timed to complement and strengthen the university’s existing capabilities in organic chemistry, medicinal chemistry and biochemistry, including the recent launch of the university’s Centre for Drug Discovery. That centre represents Bath’s ambition to build an integrated pipeline in which fundamental molecular science, biological evaluation and translational development operate in close proximity. Appointing a chair of Bower’s calibre to anchor the synthetic chemistry side of that pipeline is a strategic statement: the university intends to compete internationally not only in understanding biology but in designing and making the molecules that can modulate it. In announcing the appointment, the university described it as a significant strengthening of its growing research excellence in organic and medicinal chemistry.

Professor Matthew Jones, Head of Bath’s Department of Chemistry, was unequivocal about the significance of the hire. John, he said, is an extremely accomplished chemist, and his appointment is a major academic coup. His expertise in synthetic and medicinal chemistry, Jones added, will significantly enhance the department’s research capabilities and strengthen its growing portfolio in this area. Jones also paid tribute to the donor behind the chair, saying the department is incredibly grateful to Professor Raymond Schinazi for his extraordinary support, which has enabled Bath to attract a scientist of John’s calibre and further strengthen the university’s position as an international centre for chemistry, medicinal science and drug discovery.

For his part, Bower expressed enthusiasm about the move and about the environment he is joining. He said he is thrilled to be joining the University of Bath as the Raymond Schinazi and Family Chair of Science, noting that Bath has an outstanding reputation for world-class chemistry and a strong commitment to translating fundamental research into real-world impact. He added that he looks forward to working with colleagues across the university to develop his research in ways that can ultimately support the translation of research to application. That translation-focused language echoes the founding purpose of the chair itself, and it suggests that Bower’s laboratory will be expected to operate not merely as a generator of elegant synthetic methods but as a source of chemistry that can flow directly into drug discovery programmes.

The broader significance of the appointment lies in what it says about the state of British chemistry and the philanthropy that increasingly supports it. Endowed chairs funded by private gifts remain comparatively rare in UK science, and one established by an alumnus whose own chemistry produced medicines used by millions of patients gives the position a symbolic resonance few appointments can match. It links a department’s future to a demonstrated proof of concept: rigorous synthetic chemistry, pursued with ambition and translated with determination, can change the course of global public health. As Bower builds his group at Bath, the expectation, set by both the donor and the university, is that the molecules his team learns to make will not simply advance the art of synthesis but move steadily closer to the clinic, continuing a tradition that began with the man whose name now heads the chair.

Subject of Research: Appointment of synthetic and medicinal chemist Professor John Bower as the Raymond Schinazi and Family Chair of Science at the University of Bath

Article Title: Top synthetic and medicinal chemist joins Bath as new Schinazi and Family Chair of Science

Article References: Top synthetic and medicinal chemist joins Bath as new Schinazi and Family Chair of Science. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: John Bower, University of Bath, Raymond Schinazi, synthetic chemistry, medicinal chemistry, drug discovery, catalysis, organic chemistry, antiviral drugs, philanthropy, Regius Professor, Centre for Drug Discovery

The scale of the donation reflects an unusual fundraising model in which corporate giving amplifies grassroots employee participation. This year’s campaign included more than $766,000 in contributions from employees of the Energy Transfer family of partnerships, which the company matched with corporate funds at a rate of 50 percent. Since the effort began in 2014, employees have led fundraising initiatives that have resulted in more than $20 million donated to UT MD Anderson, and the combined total of company support now exceeds $21 million. That longevity matters in biomedical research, where multi-year funding streams allow laboratories to plan experiments, retain specialized staff, and pursue lines of investigation that may take years to bear fruit.

Leadership at Energy Transfer framed the gift as an expression of a shared institutional mission rather than a one-time gesture. Tom Long, co-Chief Executive Officer of Energy Transfer, said the commitment employees have shown to UT MD Anderson over the years reflects a shared belief in the power of innovation to change lives. He noted that the breakthroughs happening at the cancer center, and the hope they bring to patients and their families, reinforce the importance of the collaboration. Such statements underscore a growing trend in which private companies channel philanthropic resources toward translational biomedical science, bridging gaps that conventional grant funding does not always cover.

At MD Anderson, the funds arrive at a moment when pediatric oncology is undergoing a significant transformation. Childhood cancers are, in many respects, distinct diseases from their adult counterparts, driven by different genetic alterations and arising in tissues that are still developing. That biological reality means that treatments designed and tested primarily in adults cannot simply be transplanted into pediatric care without careful adaptation. Researchers in pediatric divisions therefore focus on identifying the molecular vulnerabilities unique to childhood tumors, developing age-appropriate dosing and treatment protocols, and minimizing the long-term side effects that can follow young patients for decades after they are declared cancer free.

Richard Gorlick, M.D., division head and chair of Pediatrics at UT MD Anderson, emphasized the role that sustained private generosity plays in that enterprise. He said that Energy Transfer, Sunoco and USA Compression employees continue to demonstrate an extraordinary commitment to children and families facing cancer, and that their generosity helps researchers pursue new discoveries and translate those advances into better treatments and outcomes for patients across the country. The language of translation is significant: moving a laboratory finding, such as the identification of a drug target or a new biomarker, into a clinically validated therapy requires resources that sit outside the standard cycle of federal research grants, particularly during the early and risky stages of development.

The human dimension of that research pipeline was on display in this year’s campaign through its patient ambassador, Braeden Cochran, whose medical journey illustrates how clinical research can change the trajectory of a young life. Cochran was diagnosed as a college freshman with a rare sub-type of blood cancer known as non-Hodgkin B-cell lymphoma, a disease in which immune cells called B cells grow uncontrollably. He began treatment at UT MD Anderson in 2024, a point he describes as a turning point in his care. Now 21, he has become a public face of the fundraising effort, demonstrating to employee donors the concrete consequences of their contributions.

Cochran’s treatment included participation in an immunotherapy-based clinical trial, an approach that has reshaped the treatment landscape for several blood cancers in recent years. Immunotherapy works differently from conventional chemotherapy: rather than directly poisoning rapidly dividing cells, it recruits or engineers the patient’s own immune system to recognize and attack malignant cells. For patients, this can mean the ability to tolerate comprehensive treatment protocols more effectively, with different and often more manageable side effects than those associated with intensive traditional regimens. Cochran credited the trial with enabling him to better tolerate his full course of treatment, an outcome that reflects the careful design work that goes into matching patients with experimental approaches suited to their disease.

Equally telling is what Cochran said about the environment in which he received care. He recalled that he did not really have the same confidence in his own healing until he came to UT MD Anderson, and that was where things really started to turn around for him. He described the experience of standing in his hospital room and seeing the research buildings on the same campus just outside, noting that it was encouraging to know that work on new treatments was being done all the time. That physical proximity between bedside and laboratory is a defining feature of comprehensive cancer centers, where clinicians and researchers operate in parallel and patient needs can inform research priorities in near real time.

Today, Cochran is cancer free and back in school, an outcome he attributes to the advanced lifesaving treatment options and expert care he received at the institution. Stories of this kind carry weight beyond their emotional resonance. For the thousands of employees who participate in the annual giving campaign, a named ambassador provides a tangible connection between payroll deductions and scientific progress, and for the researchers who depend on philanthropic support, patient outcomes serve as the clearest possible justification for continued investment in early-stage and high-risk science.

The $2.2 million gift thus arrives as both a financial milestone and a case study in how modern cancer research is funded. Federal agencies remain the largest source of basic biomedical research support, but philanthropy increasingly fills critical roles: seeding pilot studies, supporting clinical trials that test novel immunotherapy approaches, funding young investigators, and sustaining the infrastructure that allows discoveries to move from bench to bedside. With more than $21 million contributed since 2014 and this year’s record total, the Energy Transfer family of partnerships has built one of the more enduring corporate-employee philanthropic partnerships in pediatric oncology. For the children and young adults treated at UT MD Anderson, and for the researchers racing to develop the next generation of therapies, the donation represents something more than a number: it is continued momentum for a scientific enterprise whose ultimate measure is measured in patients who, like Cochran, return to their studies and their lives after cancer.

Subject of Research: Philanthropic funding of pediatric cancer research and immunotherapy clinical trials at UT MD Anderson Cancer Center

Article Title: Energy Transfer and Sunoco donate $2.2 million to support pediatric cancer research at UT MD Anderson

Article References: Energy Transfer and Sunoco donate $2.2 million to support pediatric cancer research at UT MD Anderson. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: pediatric cancer, MD Anderson, Energy Transfer, Sunoco, philanthropy, immunotherapy, clinical trial, non-Hodgkin lymphoma, employee giving campaign, cancer research funding, pediatric oncology, translational research

The timing of the announcement is not incidental. The organization arrives at a moment of mounting anxiety among epidemiologists and global health officials, as shrinking foreign aid budgets strain disease surveillance programs across the developing world and as experts warn that the conditions for another pandemic are quietly accumulating. In the months leading up to its public unveiling, Schmidt Global Health has already been operating behind the scenes, boosting public health monitoring for the 2026 World Cup, preserving an essential database of Ebola statistics, symptoms, and treatments, and supporting measles response efforts in the United States and the Pacific Islands. These early projects offer a preview of the organization’s operating philosophy: move fast, plug critical gaps, and build durable capacity rather than one-off interventions.

Wendy Schmidt, who serves as president and co-founder of the new organization, is scheduled to discuss its work at the World Health Summit in Berlin, with a livestream available to a global online audience. Her framing of the mission emphasizes the borderless nature of modern biological risk. In a statement accompanying the launch, she argued that in a world as deeply interconnected as ours, in which challenges respect no borders, solutions need to be as swift, responsive, and far-reaching as the problems themselves. She described the organization as embracing the challenge of answering an urgent international need in a rapid yet systemic way, working toward a philanthropic vision of a healthy, resilient, and secure world for all.

The technical core of Schmidt Global Health rests on four interconnected pillars of work. The first, Network, fosters collaboration across a global web of medical professionals, researchers, and public health officials, recognizing that outbreak intelligence is only as good as the human connections that carry it. The second, Information and Analysis, applies artificial intelligence, machine learning, and other computational technologies to accelerate research, analysis, and the transparent, real-time sharing of information. The third, Communication, aims to make public health news accessible and actionable for communities, addressing the well-documented failure of technical warnings to reach the people who need them most. The fourth, Emergency Response, builds resilience to prepare for and respond to public health emergencies before they cascade into catastrophes.

The application of artificial intelligence to epidemic detection is among the most consequential technical bets embedded in this strategy. Eric Schmidt, co-founder of the organization and a longtime advocate for American leadership in AI, noted that AI is already transforming the world of medicine by accelerating data collection and analysis, the discovery of treatments, and the dissemination of information and care. With Schmidt Global Health, he said, that impact can be deepened with the explicit hope of preventing the next pandemic before it starts. In practice, this means deploying machine learning models to sift through vast, noisy streams of open-source data, from clinical reports to news feeds, to surface early signals of unusual disease activity that traditional reporting systems might catch too late or miss entirely.

The organization’s grantmaking portfolio illustrates how these ambitions translate into concrete support for working public health systems. Schmidt Global Health funds the World Health Organization’s Health Emergencies Programme, which is currently scaling up support for the governments of the Democratic Republic of the Congo and Uganda in response to an active Ebola crisis, strengthening surveillance, contact tracing, clinical preparedness and management, supply delivery, community engagement, and cross-border preparedness. It also supports the WHO Hub for Pandemic and Epidemic Intelligence in Berlin, including the Epidemic Intelligence from Open Sources platform, the world’s leading initiative for open-source intelligence in public health decision-making, and the GOARN Berlin Fellowship Programme, which trains the next generation of outbreak responders.

Human capital receives particular attention across the portfolio. The WHO Berlin Hub’s Syrian Field Epidemiology Training Program supports the training of local epidemiologists in disease tracking, outbreak investigation, data analysis, rapid response, and the use of AI tools for public health, an investment in expertise within a health system devastated by more than a decade of conflict. In the United States, the organization funds the Council of State and Territorial Epidemiologists’ Applied Epidemiology Fellowship and its Leading Epidemiologists, Advancing Data Fellowship, both designed to improve coordination across public health jurisdictions for epidemiologic reporting and information sharing while preparing for global events such as the World Cup, which concentrates enormous, mobile crowds and creates distinctive surveillance challenges.

Data preservation and regional cooperation form a third strand of the work. The Sierra Leone Ebola Database, a joint project of the Sierra Leone Ministry of Health and Sanitation and the Centers for Disease Control and Prevention, preserves and manages treatment, testing, death, burial site, risk factor, and symptom data from the 2014 to 2016 West African Ebola outbreak, serving both the humanitarian purpose of helping families visit their loved ones’ resting places and the scientific purpose of providing a vital research resource for preparing for future outbreaks. In the Pacific, the organization supports the Pacific Public Health Surveillance Network, a voluntary coalition spanning 22 island countries and territories that detects and responds to emergencies including dengue fever, measles, typhoid, and cholera, with funding directed toward data collection and field epidemiology training in partnership with the Pacific Community and the Pacific Island Health Officers Association.

Communication and clinical research round out the portfolio. Schmidt Global Health supports The Conversation, a nonprofit, independent news organization that translates peer-reviewed research into accessible journalism, whose stories were read 550 million times across its global network in the past year, an acknowledgment that public understanding is itself a public health intervention. The organization also carries forward the clinical legacy of the Schmidt Initiative for Long Covid, funding scientists at Nova Southeastern University, Western University, and Scripps Research who are testing whether therapies already approved by the FDA for other conditions can provide relief from Long Covid symptoms, using AI to cross-reference drugs against the largest set of patient and proteomic data of any similar studies and conducting the first fully remote clinical trial for the condition.

John Redd, chief executive officer of Schmidt Global Health, framed the launch as a response to a structural void in the global health landscape. Philanthropy, he argued, has an opportunity to fill a gap in the public health landscape to improve pandemic detection and response, and he expressed enthusiasm for expanding the Long Covid initiative’s model to take on more public health challenges at a time of immense need worldwide. Whether a private foundation can meaningfully offset the erosion of government-funded surveillance remains an open question, but the organization’s early record, from World Cup monitoring to Ebola data preservation to Pacific measles response, suggests a strategy built on speed, technical leverage, and partnership with the professionals already doing the work. As the architects of the new nonprofit see it, the cost of the next pandemic will dwarf the cost of the systems needed to stop it, and the time to build those systems is now.

Subject of Research: A new philanthropic nonprofit strengthening global public health surveillance and pandemic response systems

Article Title: Eric and Wendy Schmidt announce global public health nonprofit to improve systems that monitor, identify, respond to health threats

Article References: Eric and Wendy Schmidt announce global public health nonprofit to improve systems that monitor, identify, respond to health threats. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Schmidt Global Health, global public health, pandemic preparedness, disease surveillance, artificial intelligence, epidemiology, World Health Organization, Ebola, Long Covid, field epidemiology training, open-source epidemic intelligence, philanthropy

The scale of the funding immediately places the program in rare territory. Each Presidents’ Impact Scholar will receive $80,000 per year for four years, a package the university says is comparable to the most generous offers at top Ivy League institutions and, nationally, in a category of its own. That level of support matters for reasons that go beyond prestige. Doctoral students in Canada have long faced funding levels that push many talented candidates toward industry or toward universities abroad, and the new award is explicitly framed as a magnet for the best minds from Canada and around the world. The program is expected to become one of the most competitive PhD awards in the country, and the university argues it will function as a new model of doctoral education for the twenty-first century.

The structural innovation at the heart of the program is the annual theme. Each year, the university will select a significant societal challenge, a major question or vexing problem facing society, and recruit a cohort of twelve or more scholars based on their potential to advance meaningful work in that area. The theme changes annually, so each cohort forms a concentrated cluster of interdisciplinary talent around a distinct research frontier. The university offers a concrete illustration: a theme such as AI and Health could mobilize computer science, quantum computing, ethical and regulatory law, ethics and philosophy, social science, and AI safety and alignment in a sustained effort to address the multi-faceted challenge of designing, adopting and regulating artificial intelligence technologies in Canadian health care. Another example given is Sovereignty and the Arctic, a problem that similarly resists any single disciplinary lens.

Supervision is being redesigned along the same lines. Every scholar in the program will work with two faculty supervisors from different disciplines, a co-supervision structure intended to ensure that students develop the deep interdisciplinary expertise needed to catalyze advances in complex fields spanning multiple domains of knowledge. This is a meaningful departure from the traditional single-advisor model that still dominates doctoral training in most fields. The university’s argument is that the hardest contemporary problems, whether in biomedicine, climate, security or technology governance, do not respect departmental boundaries, and that the researchers best positioned to solve them are those trained from the outset to move fluently between ways of knowing.

Real-world engagement is the second pillar of the design. Presidents’ Impact Scholars will participate in an external engagement experience intended to enhance their capacity for practical problem-solving. That could take the form of a government partnership, an international placement, or an internship with industry partners doing relevant work. The program will also run extensive programming connecting each cohort with other researchers across the university, including graduate students, postdoctoral fellows and faculty members pursuing work related to the cohort’s theme. Engagement opportunities and support will flow through university communities such as U of T Entrepreneurship, signaling that the program treats commercialization and knowledge mobilization as legitimate and encouraged outcomes of doctoral research, not as distractions from it.

Selection criteria reflect this dual emphasis on scholarly excellence and practical impact. Candidates will be evaluated for academic excellence, but also for their track record in innovation and real-world problem-solving. The university notes that its scholars will be just as likely to be applied innovators committed to transforming brilliant ideas into meaningful public or commercial impact as they are to be outstanding scholars driving large-scale interdisciplinary research or shaping new paradigms of understanding in a specific field. In other words, the program is deliberately widening the definition of what a top doctoral candidate looks like, betting that curiosity, imagination and entrepreneurial daring are as predictive of future influence as conventional academic metrics.

University leadership has framed the initiative as a response to a changing world. President Melanie Woodin said that as Canada and the world face challenges of increasing complexity, future solutions will require new ideas and fresh thinking that cuts across disciplines, and she described the program as a major innovation in PhD education that will galvanize a new generation of thought leaders who will serve as key contributors to the prosperity of the country. Joshua Barker, dean of the School of Graduate Studies and vice-provost of graduate research and education, called the approach visionary, saying that Presidents’ Impact Scholars will benefit from a learning experience that sets a new standard for interdisciplinary, real-world problem-solving at the highest levels, and that they will be part of a cohort of exceptional peers working together on meaningful research and complex challenges, creating a collaborative community that enriches the doctoral experience.

Trevor Young, the university’s vice-president and provost, emphasized the systemic role doctoral students play in the research enterprise. PhD students, he said, are the backbone of the country’s research and innovation ecosystem, and through the program the university is making a generational investment in brilliant students from every conceivable discipline and background, empowering them to take on the biggest problems, including future challenges not yet known or understood. The university points to its doctoral legacy as context: students associated with Toronto have contributed to some of the biggest advances of the past century, from building the first electron microscope in North America to developing machine learning and deep neural networks. The new program, administrators suggest, opens a new chapter in that history, with the capacity to lift research across fields critical to Canada’s future, including artificial intelligence, quantum technologies, genomics, biomedical sciences, sustainability, public policy and cybersecurity.

The philanthropic story behind the program is itself notable. The enabling $50-million gift comes from a Canadian family foundation with a deep, long-standing history of support for the University of Toronto as well as other post-secondary institutions and research centres focused on encouraging innovative, multidisciplinary approaches to complex problems. The family wishes to remain anonymous. David Palmer, the university’s vice-president of advancement, said it is deeply gratifying to see the extraordinary investment and engagement of the philanthropic community with the university’s efforts to elevate and transform graduate education in Canada, describing the gift as an inspiring example of thoughtful philanthropy that raises institutional sights and transforms the collective potential to generate beneficial change for future generations. The university’s matching funds bring the total commitment to $100 million, and the endowment structure is intended to sustain the fellowship in perpetuity.

The launch also fits into a broader, coordinated push. Since 2024, working with philanthropic champions and public partners, the university has moved from a substantial graduate funding increase to a full suite of recruitment, recognition and research support programs for graduate students and postdoctoral scholars, and the new program builds directly on that momentum. Administrators argue the payoff could extend well beyond campus: by concentrating interdisciplinary talent on themes with clear national relevance, the program has the potential to advance knowledge mobilization in areas that strengthen and sustain Canada’s future prosperity and innovation while improving quality of life for communities across the country. A call for applications will be issued soon, and the inaugural cohort of Presidents’ Impact Scholars will begin their studies in September 2027. If the model works as designed, it could offer a template that other research-intensive universities, in Canada and abroad, will be pressed to imitate.

Subject of Research: A new interdisciplinary PhD scholarship program at the University of Toronto funded by a $100-million investment

Article Title: U of T transforms PhD education with launch of Presidents’ Impact Scholarship Program

Article References: U of T transforms PhD education with launch of Presidents’ Impact Scholarship Program. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: University of Toronto, PhD education, Presidents' Impact Scholarship, interdisciplinary research, doctoral funding, philanthropy, AI and health, knowledge mobilization, graduate education, research innovation, Canada, cohort model

The center builds long-term partnerships with schools, community organizations, and families with the explicit goal of improving learning outcomes for students from pre-kindergarten through 12th grade. Its approach is grounded in research, evaluation, technical assistance, and school-based implementation, and it works to create equitable pathways for student success and community well-being. In practice, that work ranges from providing school-based social-emotional support to helping families and students meet basic needs such as food and housing. The model reflects a growing consensus in education research that academic achievement cannot be separated from the conditions in which children live. By embedding university resources directly within schools and communities, the center seeks to address those conditions where they arise rather than treating them as problems for schools to solve alone.

Laura Bronstein, dean of the College of Community and Public Affairs and founding director of the newly renamed center, described the gift as a catalyst for the program’s continuing mission. “The center has become a leader in the university-assisted community schools (UACS) model, and this gift really allows us to continue and expand our mission,” Bronstein said. “We are grateful to the donors for their ongoing support for what we do and for believing in our mission to make education accessible and impactful for all.” Her comments underscore the dual role the center plays: it is both an operating program that places university students and staff in local schools and a scholarly enterprise that studies what works in community school implementation and shares those findings across the state and beyond.

The funding will allow the center to continue and build upon a set of existing initiatives that together form the backbone of its work. Among the most visible of these is the placement of hundreds of Binghamton University students as interns and volunteers in schools, where they provide tutoring, mentoring, and social-emotional support to students from early grades through high school. The center also provides technical support and training to community schools around New York State, extending its reach well beyond the districts immediately surrounding the university. In addition, it conducts interdisciplinary research to evaluate student outcomes, generating evidence about how the community schools model affects attendance, engagement, academic performance, and family well-being. The new gift is intended to sustain and deepen each of these strands of activity.

The donors behind the gift were the late Janet C. Watrous and Robert Kochersberger, a couple with longstanding ties to the university who had previously dedicated the Charlie K. Community Schools Room, named for their son. The naming of the center itself carries personal and institutional significance. The first half of the Couper-Owens name honors the Couper family, founding figures in Binghamton University’s history, while the second half pays tribute to Kochersberger’s late mother, Marjorie Mae Owens, a school nurse in rural Western New York who was known for bringing food and clothing to the homes of her students in need. That history of direct, practical care for children echoes the center’s own philosophy of meeting students and families where they are.

Kochersberger explained that the gift reflected both family history and a conviction about the program’s distinctive reach. “The new center gave me and my late wife the opportunity to support it in a more tangible way, something that we really wanted to do, because our son was a former elementary school teacher, my mother was an elementary school nurse,” he said. “And we’ve just felt really strongly about supporting this program because it is almost unique in the country for the outreach that it does into public schools.” His characterization of the program as nearly singular in its depth of public school outreach highlights what distinguishes a full university-assisted model from more limited school-university partnerships: the integration of university personnel, research capacity, and student volunteers into the daily operations of schools over sustained periods.

Binghamton University President Anne D’Alleva framed the center’s work as an embodiment of the university’s broader public mission, praising the program as a national and global leader in community schools. “Community engagement, just like celebrating our history and traditions, is a critically important part of what we do,” D’Alleva said. “And I often talk about the four pillars of our work as a great public university in education, research and scholarship, economic development, and community engagement. And this program touches on everything we do and need to do as a great public university. So I am so grateful for this support. I am so grateful that we are moving this program forward and that we will continue to have impact through it, not only and most importantly in our surrounding communities, but across the state, nationally, and globally.”

For Luann Kida, senior director of capacity building and implementation at the Couper-Owens Center for Community Schools, the durability of relationships with local school districts is the key to the model’s effectiveness. “This isn’t a program that is set up down the hall and forgotten about,” Kida said. “We’re reaching families and making a real impact. We strive to create meaningful partnerships with schools, supporting their important work while trying to break the intergenerational cycle that so many kids and families get caught up in. Community schools bring together schools, families, and community partners to address barriers, creating learning environments where children can thrive.” Her emphasis on breaking intergenerational cycles points to the long time horizons involved: community schools are designed not as short-term interventions but as permanent institutional fixtures that serve successive cohorts of children within the same neighborhoods.

The technical core of the university-assisted community schools model lies in its integration of services that are typically scattered across separate agencies. Expanding mental health services and making them available directly in schools is a key initiative of the UACS model at Whitney Point, one of the districts the center serves, where social work interns meet with students inside the high school rather than requiring families to navigate external clinics and waiting lists. That placement matters for outcomes: school-based services reduce transportation and scheduling obstacles, reach children who might otherwise go unserved, and allow social workers and counselors to coordinate with teachers who see students every day. Similar logic applies to the center’s work on basic needs, where connecting families to food and housing assistance removes obstacles that research consistently links to absenteeism and disengagement.

As the Couper-Owens Center for Community Schools moves forward under its new name, the $1 million gift positions it to extend a model that Binghamton University leaders describe as influential well beyond the Southern Tier of New York. The combination of sustained school partnerships, a pipeline of university student interns and volunteers, statewide technical assistance, and interdisciplinary evaluation research gives the center an unusually complete footprint within the community schools field. With the dedication ceremony at the University Downtown Center now behind it, the center’s task is to convert new philanthropic support into continued and expanded impact for students from pre-K through 12th grade, in the surrounding communities first and, as D’Alleva noted, across the state, nationally, and globally.

Subject of Research: University-assisted community schools and philanthropic support for expanding student services at Binghamton University

Article Title: Binghamton University community schools center gets new name, $1 million boost

Article References: Binghamton University community schools center gets new name, $1 million boost. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Binghamton University, community schools, university-assisted community schools, philanthropy, education, student outcomes, mental health services, school partnerships, New York State, College of Community and Public Affairs, social-emotional support, educational equity